CHAPTER 1.Industry Overview of Liver Disease Diagnostics
1.1.Definition and Scope
1.1.1.Definition of Liver Disease Diagnostics
1.1.2.Market Segmentation
1.1.3.Years Considered for the Study
1.1.4.Assumptions and Acronyms Used
1.1.4.1.Market Assumptions and Market Forecast
1.1.4.2.Acronyms Used in Global Liver Disease Diagnostics Market
1.2.Summary
1.2.1.Executive Summary
1.2.2.Liver Disease Diagnostics Market By Technique
1.2.3.Liver Disease Diagnostics Market By End Use
1.2.4.Liver Disease Diagnostics Market by Regions
CHAPTER 2.Research Approach
2.1.Methodology
2.1.1.Research Programs
2.1.2.Market Size Estimation
2.1.3.Market Breakdown and Data Triangulation
2.2.Data Source
2.2.1.Secondary Sources
2.2.2.Primary Sources
CHAPTER 3.Market Dynamics And Competition Analysis
3.1.Market Drivers
3.1.1.Driver 1
3.1.2.Driver 2
3.2.Restraints and Challenges
3.2.1.Restrain 1
3.2.2.Restrain 2
3.3.Growth Opportunities
3.3.1.Opportunity 1
3.3.2.Opportunity 2
3.4.Porter’s Five Forces Analysis
3.4.1.Bargaining Power of Suppliers
3.4.2.Bargaining Power of Buyers
3.4.3.Threat of Substitute
3.4.4.Threat of New Entrants
3.4.5.Degree of Competition
3.5.Market Concentration Ratio and Market Maturity Analysis of Liver Disease Diagnostics Market
3.5.1.Go To Market Strategy
3.5.1.1.Introduction
3.5.1.2.Growth
3.5.1.3.Maturity
3.5.1.4.Saturation
3.5.1.5.Possible Development
3.6.Technological Roadmap for Liver Disease Diagnostics Market
3.7.Value Chain Analysis
3.7.1.List of Key Manufacturers
3.7.2.List of Customers
3.7.3.Level of Integration
3.8.Cost Structure Analysis
3.8.1.Price Trend of Key Raw Materials
3.8.2.Raw Material Suppliers
3.8.3.Proportion of Manufacturing Cost Structure
3.8.3.1.Raw Material
3.8.3.2.Labor Cost
3.8.3.3.Manufacturing Expense
3.9.Regulatory Compliance
3.10.Competitive Landscape, 2020
3.10.1.Player Positioning Analysis
3.10.2.Key Strategies Adopted By Leading Players
CHAPTER 4.Manufacturing Plant Analysis
4.1.Manufacturing Plant Location and Establish Date of Major Manufacturers in 2020
4.2.R&D Status and Application Source of Liver Disease Diagnostics Major Manufacturers in 2020
CHAPTER 5.Liver Disease Diagnostics Market By Technique
5.1.Introduction
5.2.Liver Disease Diagnostics Revenue By Technique
5.2.1.Liver Disease Diagnostics Revenue (US$ Mn) and Forecast, By Technique, 2017-2028
5.2.2.Laboratory tests
5.2.2.1.Laboratory tests Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
5.2.3.Imaging
5.2.3.1.Imaging Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
5.2.4.Biopsy
5.2.4.1.Biopsy Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
5.2.5.Endoscopy
5.2.5.1.Endoscopy Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
5.2.6.Others
5.2.6.1.Others Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
CHAPTER 6.Liver Disease Diagnostics Market Revenue By End Use
6.1.Introduction
6.2.Liver Disease Diagnostics Revenue (US$ Mn) By End Use
6.2.1.Liver Disease Diagnostics Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
6.2.2.Hospitals & Clinics
6.2.2.1.Hospitals & Clinics Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
6.2.3.Laboratories
6.2.3.1.Laboratories Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
6.2.4.Others
6.2.4.1.Others Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
CHAPTER 7.North America Liver Disease Diagnostics Market By Country
7.1.North America Liver Disease Diagnostics Overview
7.2.U.S.
7.2.1.U.S. Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By Technique, 2017-2028
7.2.2.U.S. Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028
7.3.Canada
7.3.1.Canada Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By Technique, 2017-2028
7.3.2.Canada Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028
7.4.North America PEST Analysis
CHAPTER 8.Europe Liver Disease Diagnostics Market By Country
8.1.Europe Liver Disease Diagnostics Market Overview
8.2.U.K.
8.2.1.U.K. Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By Technique, 2017-2028
8.2.2.U.K. Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028
8.3.Germany
8.3.1.Germany Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By Technique, 2017-2028
8.3.2.Germany Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028
8.4.France
8.4.1.France Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By Technique, 2017-2028
8.4.2.France Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028
8.5.Spain
8.5.1.Spain Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By Technique, 2017-2028
8.5.2.Spain Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028
8.6.Rest of Europe
8.6.1.Rest of Europe Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By Technique, 2017-2028
8.6.2.Rest of Europe Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028
8.7.Europe PEST Analysis
CHAPTER 9.Asia Pacific Liver Disease Diagnostics Market By Country
9.1.Asia Pacific Liver Disease Diagnostics Market Overview
9.2.China
9.2.1.China Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By Technique, 2017 - 2028
9.2.2.China Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
9.3.Japan
9.3.1.Japan Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By Technique, 2017 - 2028
9.3.2.Japan Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
9.4.India
9.4.1.India Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By Technique, 2017 - 2028
9.4.2.India Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
9.5.Australia
9.5.1.Australia Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By Technique, 2017 - 2028
9.5.2.Australia Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
9.6.South Korea
9.6.1.South Korea Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By Technique, 2017 - 2028
9.6.2.South Korea Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
9.7.Rest of Asia-Pacific
9.7.1.Rest of Asia-Pacific Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By Technique, 2017 - 2028
9.7.2.Rest of Asia-Pacific Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
9.8.Asia Pacific PEST Analysis
CHAPTER 10.Latin America Liver Disease Diagnostics Market By Country
10.1.Latin America Liver Disease Diagnostics Market Overview
10.2.Brazil
10.2.1.Brazil Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By Technique, 2017 - 2028
10.2.2.Brazil Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
10.3.Mexico
10.3.1.Mexico Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By Technique, 2017 - 2028
10.3.2.Mexico Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
10.4.Rest of Latin America
10.4.1.Rest of Latin America Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By Technique, 2017 – 2028
10.4.2.Rest of Latin America Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
CHAPTER 11.Middle East & Africa Liver Disease Diagnostics Market By Country
11.1.Middle East & Africa Liver Disease Diagnostics Market Overview
11.2.Saudi Arabia
11.2.1.Saudi Arabia Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By Technique, 2017 - 2028
11.2.2.Saudi Arabia Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
11.3.UAE
11.3.1.UAE Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By Technique, 2017 - 2028
11.3.2.UAE Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
11.4.Rest of Middle East & Africa
11.4.1.Rest of Middle East & Africa Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By Technique, 2017 - 2028
11.4.2.Rest of Middle East & Africa Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
CHAPTER 12.Player Analysis Of Liver Disease Diagnostics
12.1.Liver Disease Diagnostics Market Company Share Analysis
12.2.Competition Matrix
12.2.1.Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2.New Product Launches and Product Enhancements
12.2.3.Mergers And Acquisition In Global Liver Disease Diagnostics Market
12.2.4.Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 13.COMPANY PROFILE
13.1.AstraZeneca
13.1.1.Company Snapshot
13.1.2.Business Overview
13.1.3.Financial Overview
13.1.3.1.Revenue (US$ Mn), 2020
13.1.3.2.AstraZeneca 2020 Liver Disease Diagnostics Business Regional Distribution
13.1.4.Product/ Service and Specification
13.1.5.Recent Developments & Business Strategy
13.1.6.Manufacturing Plant Footprint Analysis
13.2.Bayer AG
13.3.Gilead Science Inc.
13.4.Merck & Co. Inc
13.5.F. Hoffmann-La Roche AG
13.6.Sanofi
13.7.Pfizer Inc.
13.8.Novartis AG
13.9.GlaxoSmithKline plc
13.10.Others
The Liver Disease Diagnostics market value is anticipated to be worth around US$ 38.9 Bn in 2028.
The Liver Disease Diagnostics market is anticipated to grow around 6.1% CAGR amid the forecast period 2021-2028.
North America held highest market share in 2019.
Asia Pacific is projected to be the fastest growing region in the global market
AstraZeneca, Bayer AG, Gilead Science Inc., Merck & Co. Inc, F. Hoffmann-La Roche AG, Sanofi, Pfizer Inc., Novartis AG, GlaxoSmithKline plc, and Others are the prominent players in the Liver Disease Diagnostics market.
The report provides insights on global Liver Disease Diagnostics market segment by technique, by end use and major geographic regions.
global liver diagnostic is the rising prevalence of acute and chronic liver diseases. The development of reliable diagnostic tools in order to enhance early detection and patient care outcomes will accelerate research and development by key industry players and will further fuel profit growth on this global market.
Customer Satisfaction
Availability - we are always there when you need us
Fortune 50 Companies trust Acumen Research and Consulting
of our reports are exclusive and first in the industry
more data and analysis
reports published till date